Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Erik Forsblom"'
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/c35248dbc6e542ce93f89588a42a3dea
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: Hospital-acquired (HA) COVID-19 infections are known to increase morbidity and mortality. The aim of this study was to investigate the incidence and outcome of HA COVID-19 in different specialties across the wards in 18 hospitals
Externí odkaz:
https://doaj.org/article/1dbed698676d4943bd88142775d58299
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258511 (2021)
BackgroundCommensal coagulase negative Staphylococcus lugdunensis may cause severe bacteremia (SLB) and complications. Treatment of SLB is not fully established and we wanted to evaluate if infectious diseases specialist consultation (IDSC) would imp
Externí odkaz:
https://doaj.org/article/fa0eb95c9b094cbaa69e0582877da501
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0252046 (2021)
BackgroundMatrix metalloproteinase-8 (MMP-8) and tissue inhibitor of metalloproteinases-1 (TIMP-1) have been shown to predict prognosis in sepsis. However, MMP-8 and TIMP-1 in Staphylococcus aureus bacteremia (SAB) lacks evaluation and their role in
Externí odkaz:
https://doaj.org/article/8d15d0d3b39e480ab0c53d6f8a624d7b
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0167112 (2016)
The objective was to compare the prognostic impact of first week treatment with anti-staphylococcal penicillin (ASP) versus cephalosporin in methicillin-sensitive Staphylococcus aureus bacteremia (MS-SAB). Altogether 580 patients were retrospectively
Externí odkaz:
https://doaj.org/article/a031595f38654272bd61a227911036d8
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0122824 (2015)
INTRODUCTION:Rifampicin has been used as adjunctive therapy in Staphylococcus aureus bacteraemia (SAB) with a deep infection focus. However, data for prognostic impact of rifampicin therapy is unestablished including the optimal initiation time point
Externí odkaz:
https://doaj.org/article/6063e00f32b148f8849ce02ab968dba6
Autor:
Erik Forsblom, Janne Aittoniemi, Eeva Ruotsalainen, Visa Helmijoki, Reetta Huttunen, Juulia Jylhävä, Mikko Hurme, Asko Järvinen
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e87741 (2014)
IntroductionAmong patients with bacteraemia or sepsis the plasma cell-free DNA (cf-DNA) biomarker has prognostic value and Pitt bacteraemia scores predict outcome. We evaluated the prognostic value of plasma cf-DNA in patients with Staphylococcus aur
Externí odkaz:
https://doaj.org/article/fb4735ca4085474da9074f92ef909f99
Autor:
Sanna-Maria Kivivuori, Ville Holmberg, Asko Järvinen, Hanna-Riikka Kreivi, Johanna Hästbacka, Atte Meretoja, Erik Forsblom, Elisa Kortela, Maarit J Ahava, Suvi Silén
Publikováno v:
Infectious Diseases. 53:789-799
Background Men reportedly suffer from a more severe disease and higher mortality during the global SARS-CoV-2 (Covid-19) pandemic. We analysed sex differences in a low epidemic area with low overall mortality in Covid-19 in a population based setting
Male sex predicts case-fatality in SARS-CoV-2 (COVID-19) – a phenomenon linked to systemic inflammation. We compared sex-related associations of inflammation parameters and outcome in a population-based setting with low case-fatality prior to wide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2820e7cc0925c735fd079635c217adcf
Autor:
Salla Kattainen, Suvi Silén, Sanna-Maria Kivivuori, Erik Forsblom, J. Ollgren, Anu Kantele, Heli Salmi, Ville Holmberg, Atte Meretoja, Juulia Pynnönen, Johanna Hästbacka, Asko Järvinen
Publikováno v:
Clinical Microbiology and Infection
Funding Information: VH has received a grant from Finska L?kares?llskapet. AJ has received a grant from Wilhelm och Else Stockmanns stiftelse and speaker honoraria from Astellas, GlaxoSmithKline, Sanofi, Thermo Fisher, MSD, OrionPharma and UnimedicPh